BHL-MEDICAL is hereby making all its customers and distributors aware of the impact of the New European Regulatory Framework applicable to the Medical Devices sector, resulting from the direct application of the new Regulation (EU) 2017/745 (MDR) whose transitional period ends on 26 May 2021.
If you have any questions that you think need clarification, arising from the application of the MDR to your commercial relationship with BHL MEDICAL, please send an email to regulatory@bhl-medical.com.
Consult the Regulation (EU) 2017/745 (RDM).